메뉴 건너뛰기




Volumn 132, Issue 6, 2013, Pages 1451-1462

Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice

Author keywords

hepatocellular carcinoma; immunocompetent; oncolytic adenovirus; orthotopic; telomelysin

Indexed keywords

ANTINEOPLASTIC AGENT; OBP 301; ONCOLYTIC ADENOVIRUS; TELOMELYSIN; UNCLASSIFIED DRUG;

EID: 84984580947     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27770     Document Type: Article
Times cited : (20)

References (36)
  • 2
    • 34250020201 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
    • DOI 10.1053/j.gastro.2007.04.061, PII S0016508507007998
    • El-Serag HB, Rudolph KL,. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76. (Pubitemid 46890874)
    • (2007) Gastroenterology , vol.132 , Issue.7 , pp. 2557-2576
    • El-Serag, H.B.1    Rudolph, K.L.2
  • 3
    • 84984552538 scopus 로고    scopus 로고
    • Viral hepatocarcinogenesis: From infection to cancer
    • DOI 10.1111/j.1478-3231.2007.01652.x
    • Tan A, Yeh SH, Liu CJ, et al. Viral hepatocarcinogenesis: from infection to cancer. Liver Int 2008; 28: 175-88. (Pubitemid 351201032)
    • (2008) Liver International , vol.28 , Issue.2 , pp. 175-188
    • Tan, A.1    Yeh, S.-H.2    Liu, C.-J.3    Cheung, C.4    Chen, P.-J.5
  • 4
    • 67651151325 scopus 로고    scopus 로고
    • Current management strategy of hepatocellular carcinoma
    • Rampone B, Schiavone B, Martino A, et al. Current management strategy of hepatocellular carcinoma. World J Gastroenterol 2009; 15: 3210-6.
    • (2009) World J Gastroenterol , vol.15 , pp. 3210-3216
    • Rampone, B.1    Schiavone, B.2    Martino, A.3
  • 6
    • 64949153532 scopus 로고    scopus 로고
    • The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: A systematic review
    • Lau WY, Lai EC, Lau SH,. The current role of neoadjuvant/adjuvant/ chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: A systematic review. Hepatobiliary Pancreat Dis Int 2009; 8: 124-33.
    • (2009) Hepatobiliary Pancreat Dis Int , vol.8 , pp. 124-133
    • Lau, W.Y.1    Lai, E.C.2    Lau, S.H.3
  • 7
    • 54449083925 scopus 로고    scopus 로고
    • Molecular targeted therapies in hepatocellular carcinoma
    • Llovet JM, Bruix J,. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48: 1312-27.
    • (2008) Hepatology , vol.48 , pp. 1312-1327
    • Llovet, J.M.1    Bruix, J.2
  • 8
    • 47949116252 scopus 로고    scopus 로고
    • Sorafenib in advanced hepatocellular carcinoma
    • Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-90.
    • (2008) N Engl J Med , vol.359 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3
  • 9
    • 33847390325 scopus 로고    scopus 로고
    • Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter
    • DOI 10.2174/156800907780058835
    • Fujiwara T, Urata Y, Tanaka N,. Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter. Curr Cancer Drug Targets 2007; 7: 191-201. (Pubitemid 46348634)
    • (2007) Current Cancer Drug Targets , vol.7 , Issue.2 , pp. 191-201
    • Fujiwara, T.1    Urata, Y.2    Tanaka, N.3
  • 12
    • 0042674013 scopus 로고    scopus 로고
    • Telomerase-dependent oncolytic adenovirus for cancer treatment
    • DOI 10.1038/sj.gt.3301987
    • Huang TG, Savontaus MJ, Shinozaki K, et al. Telomerase-dependent oncolytic adenovirus for cancer treatment. Gene Ther 2003; 10: 1241-7. (Pubitemid 36934726)
    • (2003) Gene Therapy , vol.10 , Issue.15 , pp. 1241-1247
    • Huang, T.-G.1    Savontaus, M.J.2    Shinozaki, K.3    Sauter, B.V.4    Woo, S.L.C.5
  • 13
    • 76349086193 scopus 로고    scopus 로고
    • A phase i Study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors
    • Nemunaitis J, Tong AW, Nemunaitis M, et al. A phase I Study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. Mol Ther 2010; 18: 429-34.
    • (2010) Mol Ther , vol.18 , pp. 429-434
    • Nemunaitis, J.1    Tong, A.W.2    Nemunaitis, M.3
  • 18
    • 64049109524 scopus 로고    scopus 로고
    • Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors
    • Robinson M, Li B, Ge Y, et al. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J Virol 2009; 83: 3450-62.
    • (2009) J Virol , vol.83 , pp. 3450-3462
    • Robinson, M.1    Li, B.2    Ge, Y.3
  • 19
    • 50549091297 scopus 로고    scopus 로고
    • The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma
    • Liu TC, Hwang T, Park BH, et al. The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma. Mol Ther 2008; 16: 1637-42.
    • (2008) Mol Ther , vol.16 , pp. 1637-1642
    • Liu, T.C.1    Hwang, T.2    Park, B.H.3
  • 20
    • 44249100151 scopus 로고    scopus 로고
    • Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: A phase i trial
    • Park BH, Hwang T, Liu TC, et al. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: A phase I trial. Lancet Oncol 2008; 9: 533-42.
    • (2008) Lancet Oncol , vol.9 , pp. 533-542
    • Park, B.H.1    Hwang, T.2    Liu, T.C.3
  • 21
    • 60549100362 scopus 로고    scopus 로고
    • Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses
    • Edukulla R, Woller N, Mundt B, et al. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses. Cancer Res 2009; 69: 1448-58.
    • (2009) Cancer Res , vol.69 , pp. 1448-1458
    • Edukulla, R.1    Woller, N.2    Mundt, B.3
  • 22
    • 78049463446 scopus 로고    scopus 로고
    • Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity
    • Gurlevik E, Woller N, Struver N, et al. Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity. Mol Ther 2010; 18: 1972-82.
    • (2010) Mol Ther , vol.18 , pp. 1972-1982
    • Gurlevik, E.1    Woller, N.2    Struver, N.3
  • 23
    • 31544471137 scopus 로고    scopus 로고
    • Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses
    • DOI 10.1158/0008-5472.CAN-05-2388
    • Di Paolo NC, Tuve S, Ni S, et al. Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses. Cancer Res 2006; 66: 960-9. (Pubitemid 43165964)
    • (2006) Cancer Research , vol.66 , Issue.2 , pp. 960-969
    • Di Paolo, N.C.1    Tuve, S.2    Ni, S.3    Hellstrom, K.E.4    Hellstrom, I.5    Lieber, A.6
  • 24
    • 33750332951 scopus 로고    scopus 로고
    • Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
    • Lee YS, Kim JH, Choi KJ, et al. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Clin Cancer Res 2006; 12: 5859-68.
    • (2006) Clin Cancer Res , vol.12 , pp. 5859-5868
    • Lee, Y.S.1    Kim, J.H.2    Choi, K.J.3
  • 25
    • 30144444237 scopus 로고    scopus 로고
    • Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice
    • Wu BK, Li CC, Chen HJ, et al. Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. Biochem Biophys Res Commun 2006; 340: 916-28.
    • (2006) Biochem Biophys Res Commun , vol.340 , pp. 916-928
    • Wu, B.K.1    Li, C.C.2    Chen, H.J.3
  • 27
    • 84984563004 scopus 로고    scopus 로고
    • Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein
    • Yeh SH, Lin MW, Lu SF, et al. Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein. Hepatology 2004; 40: 847-54.
    • (2004) Hepatology , vol.40 , pp. 847-854
    • Yeh, S.H.1    Lin, M.W.2    Lu, S.F.3
  • 28
    • 84983725887 scopus 로고    scopus 로고
    • Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma
    • Yeh SH, Chen PJ, Shau WY, et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001; 121: 699-709.
    • (2001) Gastroenterology , vol.121 , pp. 699-709
    • Yeh, S.H.1    Chen, P.J.2    Shau, W.Y.3
  • 29
    • 84984572980 scopus 로고    scopus 로고
    • Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis
    • Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004; 41: 659-66.
    • (2004) J Hepatol , vol.41 , pp. 659-666
    • Yeh, S.H.1    Tsai, C.Y.2    Kao, J.H.3
  • 30
    • 0022635768 scopus 로고
    • Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells
    • DOI 10.1007/BF01315303
    • Silverstein G, Strohl WA,. Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells. Arch Virol 1986; 87: 241-64. (Pubitemid 16180329)
    • (1986) Archives of Virology , vol.87 , Issue.3-4 , pp. 241-264
    • Silverstein, G.1    Strohl, W.A.2
  • 31
    • 0022658185 scopus 로고
    • Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection
    • DOI 10.1016/0042-6822(86)90406-X
    • Eggerding FA, Pierce WC,. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology 1986; 148: 97-113. (Pubitemid 16186643)
    • (1986) Virology , vol.148 , Issue.1 , pp. 97-113
    • Eggerding, F.A.1    Pierce, W.C.2
  • 32
    • 40549146594 scopus 로고    scopus 로고
    • Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma
    • Li YM, Song ST, Jiang ZF, et al. Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1274-9.
    • (2008) World J Gastroenterol , vol.14 , pp. 1274-1279
    • Li, Y.M.1    Song, S.T.2    Jiang, Z.F.3
  • 36
    • 34248141100 scopus 로고    scopus 로고
    • A cytokine-mediated link between innate immunity, inflammation, and cancer
    • DOI 10.1172/JCI31537
    • Lin WW, Karin M,. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Investig 2007; 117: 1175-83. (Pubitemid 46718402)
    • (2007) Journal of Clinical Investigation , vol.117 , Issue.5 , pp. 1175-1183
    • Lin, W.-W.1    Karin, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.